Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Quantum Biopharma Ltd (QNTM)

Quantum Biopharma Ltd (QNTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Reports Lower Q2 Expenses, Advances Lucid-MS Into Phase 2 Investor Brand Network - Mon Aug 17, 10:41AM CDT

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.

QNTM : 3.52 (+5.39%)
QNTM.CN : 4.8000 (+6.67%)
Quantum BioPharma Strengthens Equity and Liquidity in Q2 2026 as FDA Approves Lucid-MS for Pivotal Phase 2 Clinical Trial GlobeNewswire - Fri Aug 14, 6:00AM CDT

TORONTO, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) ("Quantum" or the "Company"), has reported its financial and operational results for the second...

QNTM : 3.52 (+5.39%)
QNTM.CN : 4.8000 (+6.67%)
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Targets Disability Drivers Beyond Relapse Rates in Multiple Sclerosis Investor Brand Network - Thu Aug 13, 9:42AM CDT

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.

QNTM : 3.52 (+5.39%)
QNTM.CN : 4.8000 (+6.67%)
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Receives FDA Clearance to Advance Lucid-MS into Phase 2 Investor Brand Network - Mon Aug 10, 10:54AM CDT

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.

QNTM : 3.52 (+5.39%)
QNTM.CN : 4.8000 (+6.67%)
Quantum BioPharma Receives United States FDA Clearance To Proceed with Lucid-MS Phase 2 Trial in Progressive Multiple Sclerosis: GlobeNewswire - Mon Aug 10, 6:00AM CDT

Major Regulatory Milestone Positions Company to Initiate Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Patented First-in-Class Neuroprotective Therapy Targeting Demyelination  Lucid-MS...

QNTM : 3.52 (+5.39%)
QNTM.CN : 4.8000 (+6.67%)
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Advances MS Imaging Study with Encouraging Preliminary Results Investor Brand Network - Mon Aug 3, 12:01PM CDT

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.

QNTM : 3.52 (+5.39%)
QNTM.CN : 4.8000 (+6.67%)
Quantum BioPharma Announces Closing of Debt Settlement GlobeNewswire - Wed Jul 29, 11:18PM CDT

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, July 30, 2026...

QNTM : 3.52 (+5.39%)
QNTM.CN : 4.8000 (+6.67%)
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Executive Outlines Lucid-MS Development Strategy and Commercial Growth Plans Investor Brand Network - Tue Jul 28, 11:14AM CDT

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.

QNTM : 3.52 (+5.39%)
QNTM.CN : 4.8000 (+6.67%)
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Developing Two-Pronged Attack on Brain Disorders Affecting Millions Investor Brand Network - Wed Jul 22, 11:08AM CDT

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.

QNTM : 3.52 (+5.39%)
QNTM.CN : 4.8000 (+6.67%)
Quantum BioPharma Announces Intention to Settle Debt GlobeNewswire - Mon Jul 20, 6:00PM CDT

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, July 20, 2026...

QNTM : 3.52 (+5.39%)
QNTM.CN : 4.8000 (+6.67%)

Barchart Exclusives

This High-Yield Exchange Stock Just Raised Its Dividend by Nearly 20% Barchart - Wed Aug 19, 6:30PM CDT
Cboe Global Markets raised its quarterly dividend by 19% to $0.86 per share on Aug. 13, marking the 16th consecutive year of increases, supported by strong options trading volumes and solid second-quarter results. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.